Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.05.23 | MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings | 110 | GlobeNewswire (Europe) | NEWS RELEASE - REGULATED INFORMATION 25 May 2023, 22:30 CET MDxHealth Announces Results of its Annual and Extraordinary General Shareholders' Meetings IRVINE, CA, and HERSTAL, BELGIUM... ► Artikel lesen | |
25.05.23 | SPINEWAY: Strengthening of the cash position thanks to new financing | 403 | GlobeNewswire (Europe) | Press release Ecully, May 25, 2023 - 8 a.m. Strengthening of the cash position in support of the Group's developments "Without compromising on its values, purpose or strategy, the Spineway... ► Artikel lesen | |
25.05.23 | Vivesto AB: Interim report for the period January 2023 - March 2023 | 146 | GlobeNewswire (Europe) | SIGNIFICANT EVENTS DURING THE FIRST QUARTERContinued focus of the operations towards research and development, including a reduction in staff and overall improvement in cost control, has contributed... ► Artikel lesen | |
25.05.23 | PCAS to sell its Canadian subsidiary, PCAS Canada Inc., to DIC Corporation | 109 | GlobeNewswire (Europe) | Ecully, May 25th, 2023 PCAS to sell its Canadian subsidiary, PCAS Canada Inc., to DIC Corporation PCAS (Euronext Paris: PCA), specialized in the development of processes and production of complex... ► Artikel lesen | |
25.05.23 | Exela Technologies, Inc.: Exela Technologies Named a Leader in NelsonHall's Healthcare Payer Operational Transformation NEAT Vendor Evaluation 2023 | 132 | GlobeNewswire (Europe) | IRVING, Texas, May 25, 2023 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. ("Exela" or the "Company") (NASDAQ: XELA, XELAP), a global business process automation ("BPA") leader, announced the Company... ► Artikel lesen | |
25.05.23 | Wireless Telecom Group, Inc.: Wireless Telecom Group Announces the Sale of the Company to Maury Microwave, Inc. | 122 | GlobeNewswire (Europe) | Shareholders to Receive $2.13 Per Share in Cash Parsippany, New Jersey, USA, May 25, 2023 (GLOBE NEWSWIRE) -- Wireless Telecom Group, Inc. (NYSE American: WTT) (the "Company" or "WTT"), a leading... ► Artikel lesen | |
25.05.23 | Byggfakta Group Nordic HoldCo AB: Bulletin from Annual General Meeting | 234 | GlobeNewswire (Europe) | The following resolutions were passed at the Annual General Meeting (the "AGM") of BYGGFAKTA GROUP Nordic HoldCo AB (publ) ("Byggfakta" or the "Company") held today, on 25 May 2023.
Adoption of income... ► Artikel lesen | |
25.05.23 | Xintela AB: Interim Report January - March 2023 | 340 | GlobeNewswire (Europe) | Summary of the interim reportThe "Company" or "Xintela" refers to Xintela AB (publ), corporate registration number 556780-3480.First quarter 2023 for the groupIncome amounted to TSEK 0 (0).Loss before... ► Artikel lesen | |
25.05.23 | Zentalis Pharmaceuticals Announces Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy at the 2023 ASCO Annual Meeting | 272 | GlobeNewswire (Europe) | Strong anti-tumor activity shown in a platinum-resistant ovarian cancer population, with a confirmed ORR of 50.0% and mPFS of 7.4 months in combination with paclitaxel, and a confirmed ORR of 35.7%... ► Artikel lesen | |
25.05.23 | American Rebel Holdings Inc: American Rebel Announces New Value Line Safes and Highlights Q1 Results | 846 | GlobeNewswire (Europe) | Dramatic Increases in Revenue and Narrowing of Net Loss Due to Champion Acquisition Nashville, TN, May 25, 2023 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) - America's Patriotic... ► Artikel lesen | |
25.05.23 | Regeneron Pharmaceuticals, Inc.: Updated Linvoseltamab (BCMAxCD3) Data from Pivotal Trial Demonstrates Early, Deep and Durable Responses in Patients with Heavily Pre-treated Multiple Myeloma | 282 | GlobeNewswire (Europe) | 71% objective response rate, with 59% of patients achieving a very good partial response or better at the recommended 200 mg dose, per new data to be shared in an oral session at ASCO Benefit also... ► Artikel lesen | |
25.05.23 | Molecular Partners to Present Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 ASCO Annual Meeting | 275 | GlobeNewswire (Europe) | MP0317 demonstrates tumor-localized CD40 activation in tumor biopsies through target occupancy and immune cell activation MP0317 demonstrates a favorable safety profile across Q3W and Q1W regimens... ► Artikel lesen | |
25.05.23 | Relay Therapeutics, Inc.: Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008 | 428 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., May 25, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge... ► Artikel lesen | |
25.05.23 | Xilio Therapeutics, Inc.: Xilio Therapeutics Announces Preliminary Clinical Data from Phase 1 Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Patients with Advanced Solid Tumors | 229 | GlobeNewswire (Europe) | Encouraging preliminary anti-tumor activity observed in a patient with PD-L1 negative advanced non-small cell lung cancer Favorable preliminary safety profile for XTX101 observed at the recommended... ► Artikel lesen | |
25.05.23 | NVIDIA Announces Upcoming Events for Financial Community | 176 | GlobeNewswire (Europe) | SANTA CLARA, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- NVIDIA will present at the following events for the financial community: BofA Securities 2023 Global Technology ConferenceTuesday, June 6, 9:20... ► Artikel lesen | |
25.05.23 | Cue Biopharma, Inc.: Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting | 270 | GlobeNewswire (Europe) | As of the data cutoff date, nine of the 14 evaluable patients treated with CUE-101+ KEYTRUDA® (pembrolizumab) demonstrated tumor regression, with five confirmed partial responses (PRs) and three durable... ► Artikel lesen | |
25.05.23 | PDS Biotechnology Corporation: PDS Biotech Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with KEYTRUDA (pembrolizumab) for Head and Neck Cancer Patients | 281 | GlobeNewswire (Europe) | Interim data being presented at ASCO 2023 Annual Meeting Demonstrated median progression-free survival (PFS) of 10.4 months Demonstrated 12-month overall survival (OS) rate of 87.1%A disease control... ► Artikel lesen | |
25.05.23 | Urbanfund Corp.: Report on Financial Results for the Three Months Ended March 31, 2023 | 97 | GlobeNewswire (Europe) | TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- Mitchell Cohen, Chief Executive Officer and President of Urbanfund Corp. (TSX-V: UFC) ("Urbanfund" or the "Company"), confirmed today that the Company has... ► Artikel lesen | |
25.05.23 | Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals | 706 | GlobeNewswire (Europe) | DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined companyCombined company will have commercial products and a library of development candidates, including two clinical... ► Artikel lesen | |
25.05.23 | Costco Wholesale Corporation Reports Third Quarter and Year-to-Date Operating Results for Fiscal 2023 | 172 | GlobeNewswire (Europe) | ISSAQUAH, Wash., May 25, 2023 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation ("Costco" or the "Company") (Nasdaq: COST) today announced its operating results for the third quarter (twelve weeks)... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 3.292 |
EVOTEC | 2.632 |
TUI | 2.073 |
NEL | 1.325 |
BAYER | 1.145 |
PLUG POWER | 1.138 |
NVIDIA | 1.134 |
RHEINMETALL | 1.057 |
AMC ENTERTAINMENT | 1.034 |
DEUTSCHE BANK | 955 |
SIEMENS ENERGY | 932 |
RENK GROUP | 873 |
REDCARE PHARMACY | 727 |
COMMERZBANK | 723 |
HEIDELBERGER DRUCK | 699 |
ALIBABA | 675 |
VOLKSWAGEN | 668 |
E.ON | 617 |
BARRICK GOLD | 610 |
BYD | 591 |
RWE | 585 |
SIEMENS | 563 |
TESLA | 562 |
DEUTSCHE LUFTHANSA | 559 |
AIXTRON SE | 554 |